Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sabrina Klesse"'
Autor:
Manja Meggendorfer, Guido Kobbe, Detlef Haase, Nicolaus Kröger, Christian Thiede, Christina Ganster, Ulrich Germing, Annika Gutermuth, Piroska Klement, Felicitas Thol, Uwe Platzbecker, Peter Valent, Anne Sophie Kubasch, Wolfgang R. Sperr, Gudrun Göhring, Anna Mies, Johannes Schiller, Thomas Schroeder, Sabrina Klesse, Arnold Ganser, Claudia Haferlach, Brigitte Schlegelberger, Christian Koenecke, Christian Kandziora, Katayoon Shirneshan, Rabia Shahswar, Victoria Panagiota, Konstanze Döhner, Michael Heuser, Jan Krönke, Razif Gabdoulline, Torsten Haferlach
Publikováno v:
American Journal of Hematology. 96
Autor:
Bernd Hertenstein, M. Wattad, Jürgen Krauter, Peter Paschka, Gesine Bug, Gerhard Heil, Lars Bullinger, Jana Fabisch, Walter Fiedler, Verena I. Gaidzik, Hartmut Döhner, Sabrina Klesse, Arnold Ganser, Hartmut Kirchner, Brigitte Schlegelberger, Felicitas Thol, Alessandro Liebich, Arnold Kloos, Michael Heuser, Hubert Serve, Gudrun Göhring, Razif Gabdoulline, Anuhar Chaturvedi, Doris Kraemer, Richard F. Schlenk, L Köhler, Martin Wichmann, Konstanze Döhner, Michael Lübbert
Publikováno v:
Leukemia
We studied acute myeloid leukemia (AML) patients with lympho-myeloid clonal hematopoiesis (LM-CH), defined by the presence of DNA methyltransferase 3A (DNMT3A) mutations in both the myeloid and lymphoid T-cell compartment. Diagnostic, complete remiss
Autor:
Lars Bullinger, Richard F. Schlenk, Gudrun Göhring, Lothar Hambach, Konstantin Büttner, Albert Heim, Bennet Heida, Alessandro Liebich, Michael Heuser, Piroska Klement, Iyas Hamwi, Felicitas Thol, Hartmut Döhner, Razif Gabdoulline, Christian Kandziora, Anuhar Chaturvedi, Johannes Schiller, Martin Wichmann, Mira Pankratz, Peter Paschka, Matthias Eder, Arnold Kloos, Sabrina Klesse, Arnold Ganser, Christian Koenecke, Brigitte Schlegelberger, Madita Flintrop, Konstanze Döhner, Jürgen Krauter, Blerina Neziri, Walter Fiedler, Michael B. Stadler, Verena I. Gaidzik
Publikováno v:
Blood
Molecular measurable residual disease (MRD) assessment is not established in approximately 60% of acute myeloid leukemia (AML) patients because of the lack of suitable markers for quantitative real-time polymerase chain reaction. To overcome this lim
Autor:
Alessandro Liebich, Thomas Schroeder, Vera Dobbernack, Uwe Platzbecker, Victoria Panagiota, Christian Koenecke, Gudrun Göhring, Robert Geffers, Mira Pankratz, Patrick Löffeld, Sabrina Klesse, Arnold Ganser, Henriette Kreimeyer, Brigitte Schlegelberger, Felicitas Thol, Ulrich Germing, Hans-Heinrich Kreipe, Martin Wichmann, Rabia Shahswar, Christian Thiede, Nicolaus Kröger, Michael Heuser, Razif Gabdoulline, Guido Kobbe, Madita Flintrop, Michael Stadler
Publikováno v:
Ann Hematol
Annals of Hematology
Annals of Hematology
We integrated molecular data with available prognostic factors in patients undergoing allogeneic hematopoietic cell transplantation (alloHCT) for myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (sAML) from MDS to evaluate their imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df625bbb5bfe99e97416a61874d3db8
https://europepmc.org/articles/PMC7116654/
https://europepmc.org/articles/PMC7116654/
Autor:
Manja Meggendorfer, Wolfgang R. Sperr, Guido Kobbe, Detlef Haase, Gudrun Göhring, Claudia Haferlach, Ulrich Germing, Rabia Shahswar, Christian Kandziora, Anne Sophie Kubasch, Annika Gutermuth, Nicolaus Kroeger, Christian Thiede, Victoria Panagiota, Anna Mies, Piroska Klement, Katayoon Shirneshan, Sabrina Klesse, Arnold Ganser, Uwe Platzbecker, Brigitte Schlegelberger, Peter Valent, Felicitas Thol, Thomas Schroeder, Christian Koenecke, Christina Ganster, Johannes Schiller, Michael Heuser, Jan Krönke, Razif Gabdoulline, Torsten Haferlach, Konstanze Döhner
Publikováno v:
Blood. 132:4360-4360
Background: PPM1D is a serine/threonine phosphatase that inactivates p53 tumor suppressor pathway. Recently, PPM1D mutations have been described in clonal hematopoiesis and are more frequently found in therapy-related MDS than in primary MDS (15% vs.
Autor:
Sabrina Klesse, Arnold Ganser, Martin Wichmann, Courteney K. Lai, Piroska Klement, Gerhard Heil, Christian Koenecke, Felicitas Thol, Lothar Hambach, Sagarajit Mohanty, Arne Trummer, Alessandro Liebich, Arnold Kloos, Michael Heuser, Johannes Schiller, Razif Gabdoulline, Jürgen Krauter, Blerina Neziri, Walter Fiedler, Hartmut Kirchner, Rabia Shahswar, Zhixiong Li
Publikováno v:
Blood. 132:5259-5259
Background: ADGRE2, CCR1, CD70, and LILRB2 expressed on the surface of myeloid blasts but not normal hematopoietic stem cells, T cells or other tissues have been recently suggested as candidate chimeric antigen receptor (CAR) targets for engineered T
Autor:
Katayoon Shirneshan, Sabine Cerny-Reiterer, Christina Ganster, Detlef Haase, Gudrun Göhring, T Haferlach, Christian Thiede, N. Kroeger, Jana Fabisch, Claudia Haferlach, U. Platzbecker, L Köhler, V Panagiota, Peter Valent, Annika Gutermuth, Sabrina Klesse, Arnold Ganser, Steve Ehrlich, Brigitte Schlegelberger, Michael Heuser, Jan Krönke, Felicitas Thol, Kathrin Stamer, Christian Koenecke, Manja Meggendorfer, Guido Kobbe, Michelle Maria Araujo Cruz, Tobias Schroeder, Konstanze Döhner
Publikováno v:
Leukemia. 29(9)
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q
Autor:
Peter Paschka, Anuhar Chaturvedi, Lars Bullinger, Konstanze Döhner, Doris Kraemer, Sabrina Klesse, Arnold Ganser, Razif Gabdoulline, Brigitte Schlegelberger, Bernd Hertenstein, Alessandro Liebich, Jana Fabisch, Martin Wichmann, Walter Fiedler, Richard F. Schlenk, Gesine Bug, Arnold Kloos, Hartmut Kirchner, Michael Luebbert, Hartmut Döhner, Michael Heuser, Hubert Serve, M. Wattad, Verena I. Gaidzik, Larissa Köhler, Gudrun Göhring, Gerhard Heil, Felicitas Thol, Juergen Krauter
Publikováno v:
Blood. 126:224-224
Background: Clonal hematopoiesis of indeterminate potential (CHIP) is defined by the detection of mutations in genes like DNA methyltransferase 3A (DNMT3A) and has recently been described to occur in healthy people and to predispose them to myeloid m
Autor:
Sabrina Klesse, Arnold Ganser, Gudrun Göhring, Brigitte Schlegelberger, Victoria Panagiota, Rabia Shahswar, Michael Stadler, Michael Heuser, Vera Dobbernack, Christian Thiede, Felicitas Thol, Uwe Platzbecker, Nicolaus Kroeger, Moritz Kleine, Sabin Bhuju, Juergen Krauter, Martin Wichmann, Guido Kobbe, Robert Geffers, Wiebke Brauns, Razif Gabdoulline, Patrick Löffeld, Christian Koenecke, Elke Dammann, Thomas Schroeder
Publikováno v:
Blood. 126:912-912
Introduction: The landscape of molecular aberrations in patients with myelodysplastic syndromes (MDS) has been well characterized and has identified ASXL1, BCOR, CUX1, IDH1, IDH2, SRSF2, RUNX1, U2AF1, TP53 and others as negative prognostic markers fo
Autor:
Arnold Kloos, Felicitas Thol, Rubén Trespando Jiménez, Michael Heuser, Renate Schottmann, Arne Trummer, Sabrina Klesse, Alessandro Liebich, Arnold Ganser, Brigitte Schlegelberger, Gudrun Göhring
Publikováno v:
Blood. 126:2836-2836
Background: Atypical chronic myeloid leukemia (aCML) is a rare disorder classified as one of the MPN/MDS overlap syndromes. aCML usually presents like CML but lacks the pathognomonic BCR-ABL fusion found in CML. Most patients progress to acute myeloi